Alembic Pharmaceuticals Canada Ltd

Alembic manufactures and markets generic pharmaceutical products across the globe has grown by leaps and bounds over the last century. The company aims to explore opportunities in the therapeutic areas such as Dermatology, Oncology, and Injectable Formulations. APL also has also co-promoted a company focused on discovery and development of innovative, small molecule drugs that target signal transduction networks and ion channels for the treatment of cancer, inflammation, autoimmune diseases and metabolic disorders.